Press releases
- Co-Diagnostics, Inc. Announces First Quarter 2024 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event
- Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results
- Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test
- Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024
More ▼
Key statistics
On Thursday, Co-Diagnostics Inc (C97:FRA) closed at 1.04, 22.21% above the 52 week low of 0.851 set on Mar 25, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.04 |
---|---|
High | 1.04 |
Low | 1.04 |
Bid | 1.04 |
Offer | 1.09 |
Previous close | 1.04 |
Average volume | 205.80 |
---|---|
Shares outstanding | 31.26m |
Free float | 30.42m |
P/E (TTM) | -- |
Market cap | 35.64m USD |
EPS (TTM) | -1.20 USD |
Data delayed at least 15 minutes, as of Apr 25 2024 07:15 BST.
More ▼